Novartis AG - 예탁증서(보통주)
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
주가
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCX Institutional
Latest Disclosed Ownership4,203 shares
Latest Disclosed Value $ 642
CX Institutional reports 12.66% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 6, 2026 - CX Institutional filed a 13F-HR form disclosing ownership of 4,203 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $540,086 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 4,812 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $508,563 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-06 2026-03-31 13F NOVARTIS AG-ADR COM 66987V109 4,203 -609 -12.66 1 0.0196
2026-02-02 2025-12-31 13F NOVARTIS AG-ADR COM 66987V109 4,812 -5,484 -53.26 1 -100.00 0.0198
2025-10-23 2025-09-30 13F NOVARTIS AG-ADR COM 66987V109 10,296 -69 -0.67 1 0.00 0.0401
2025-07-16 2025-06-30 13F/A-1 NOVARTIS AG-ADR COM 66987V109 10,365 0 0.00 1 0.00 0.0437
2025-07-11 2025-06-30 13F NOVARTIS AG-ADR COM 66987V109 10,365 0 1 0.0435
2025-04-15 2025-03-31 13F NOVARTIS AG-ADR COM 66987V109 10,365 -174 -1.65 1 -99.90 0.0436
2025-01-21 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 10,539 -140 -1.31 1,026 -16.53 0.0407
2024-10-11 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,679 401 3.90 1,228 12.25 0.0545
2024-07-11 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 10,278 76 0.74 1,094 10.95 0.0514
2024-04-15 2024-03-31 13F Novartis AG Spons ADR SPONSORED ADR 66987V109 10,202 -53 -0.52 987 -4.73 0.0476
2024-01-12 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 10,255 0 0.00 1,035 -0.86 0.0554
2023-10-18 2023-09-30 13F Novartis AG Spons ADR SPONSORED ADR 66987V109 10,255 0 0.00 1,045 0.97 0.0575
2023-07-26 2023-06-30 13F NOVARTIS AG ADR SPONSORED ADR SPONSORED 66987V109 10,255 -93 -0.90 1,035 8.05 0.0536
2023-05-04 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 10,348 146 1.43 957 3.46 0.0510
2023-02-03 2022-12-31 13F NOVARTIS AG ADR SPONSORED ADR SPONSORED 66987V109 10,202 0 0.00 926 19.35 0.0562
2022-11-04 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,202 0 0.00 775 -10.09 0.0538
2022-08-02 2022-06-30 13F NOVARTIS AG-ADR COM 66987V109 10,202 0 0.00 862 -3.69 0.0651
2022-05-09 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 10,202 1,375 15.58 895 15.93 0.0717
2022-01-18 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,827 -1,375 -13.48 772 -7.43 0.0614
2021-11-10 2021-09-30 13F NOVARTIS AG-ADR COM 66987V109 10,202 0 0.00 834 -10.42 0.0681
2021-08-04 2021-06-30 13F NOVARTIS AG-ADR COM 66987V109 10,202 0 0.00 931 6.77 0.0765
2021-04-15 2021-03-31 13F NOVARTIS AG-ADR COM 66987V109 10,202 0 0.00 872 -9.45 0.0779
2021-01-12 2020-12-31 13F NOVARTIS AG-ADR COM 66987V109 10,202 -13 -0.13 963 8.45 0.0928
2020-10-13 2020-09-30 13F NOVARTIS AG-ADR COM 66987V109 10,215 -31 -0.30 888 -0.78 0.0958
2020-08-06 2020-06-30 13F NOVARTIS AG-ADR COM 66987V109 10,246 166 1.65 895 7.70 0.1176
2020-04-29 2020-03-31 13F NOVARTIS AG-ADR COM 66987V109 10,080 0 0.00 831 -12.89 0.1356
2020-01-21 2019-12-31 13F NOVARTIS AG-SPONSORED ADR COM 66987V109 10,080 -16 -0.16 954 8.78 0.1665
2019-10-10 2019-09-30 13F NOVARTIS AG-SPONSORED ADR COM 66987V109 10,096 -29 -0.29 877 -5.19 0.1417
2019-07-17 2019-06-30 13F NOVARTIS AG-SPONSORED ADR COM 66987V109 10,125 -268 -2.58 925 -7.41 0.1468
2019-04-03 2019-03-31 13F NOVARTIS AG-SPONSORED ADR COM 66987V109 10,393 326 3.24 999 15.63 0.1762
2019-01-14 2018-12-31 13F NOVARTIS AG-ADR COM 66987V109 10,067 10,067 864 0.1824
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.